skip to content
Diagnostic methods for neuropathic pain : a review of diagnostic accuracy Preview this item
ClosePreview this item
Checking...

Diagnostic methods for neuropathic pain : a review of diagnostic accuracy

Author: Canadian Agency for Drugs and Technologies in Health.; Canadian Agency for Drugs and Technologies in Health. Rapid Response Service,
Publisher: Ottawa (ON) : CADTH Rapid Response Service, [2015?]
Series: Rapid response report (Canadian Agency for Drugs and Technologies in Health)
Edition/Format:   eBook : Document : English
Database:WorldCat
Summary:
Compared to nociceptive or inflammatory pain, individuals with neuropathic pain (NP) suffer from more severe disease, greater costs, and relatively reduced health related quality of life. Direct and indirect costs of NP represent a substantial economic burden on the Canadian healthcare system with per patient costs estimated at $2567 ((+/- ) $2711) per three month care period. Neuropathic pain is defined by the  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Review
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Canadian Agency for Drugs and Technologies in Health.; Canadian Agency for Drugs and Technologies in Health. Rapid Response Service,
OCLC Number: 923138142
Notes: Title from PDF caption.
"07 April 2015."
Description: 1 online resource (1 PDF file (29 pages)) : illustration.
Series Title: Rapid response report (Canadian Agency for Drugs and Technologies in Health)
Responsibility: prepared by Canadian Agnecy for Drugs and Technologies in Heath.

Abstract:

Compared to nociceptive or inflammatory pain, individuals with neuropathic pain (NP) suffer from more severe disease, greater costs, and relatively reduced health related quality of life. Direct and indirect costs of NP represent a substantial economic burden on the Canadian healthcare system with per patient costs estimated at $2567 ((+/- ) $2711) per three month care period. Neuropathic pain is defined by the International Association for the Study of Pain (IASP) as "pain arising as a direct consequence of a lesion or disease affecting the somatosensory system". The etiology of NP is broad and associated conditions (e.g., cancer, surgery, diabetes, herpes zoster) have been classified into four distinct categories: peripheral nervous system focal and multifocal legions (e.g., post-herpetic neuralgia); peripheral nervous system generalized polyneuropathies (e.g., diabetic neuropathy); central nervous system lesions (e.g., spinal cord injury); and, complex neuropathic disorders including complex regional pain syndrome types I and II. While rates of NP-associated conditions are well documented, rates of NP in the general population are difficult to quantify and under-diagnosed. Studies in the United Kingdom and France that utilized screening tools to identify NP have estimated that 6-8% of patients with chronic pain experience NP in the general population. A single Canadian study that used telephone-based questionnaires for determining NP rates estimated a higher (18%) rate in the general population. Limitations and lack of standardization of diagnostic methods increase the potential for undetected or poorly classified cases. There is no recognized objective gold standard for assessing NP. However, the Special Interest Group on Neuropathic Pain (NeuPSIG) of the IASP has set out a grading system that has been used to guide clinical assessment and diagnosis. This approach involves multiple steps including obtaining a clinical history of pain, assessing the neuroanatomical plausibility of pain, using sensory assessments to confirm nervous system involvement, and running diagnostic tests to confirm nervous system lesions or disease. Other less resource intensive methods of diagnosis have been documented and may be especially useful in primary care. These strategies include, but are not limited to NP screening tools such as: the Douleur Neuropathique 4 (DN4), PainDETECT (PD-Q) the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), and the standardized evaluation of pain (StEP). Screening tools are comprised of an interview component and, in some cases, the addition of a brief bedside clinical assessment. Many of these tools have been translated for application in other languages and populations. Given observed variation in the approach to diagnosis of NP and the significant disease burden, it is of interest to assess the diagnostic accuracy of methods of assessing NP. Improved diagnostic procedures may facilitate improvements in treatment approaches.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/923138142> # Diagnostic methods for neuropathic pain : a review of diagnostic accuracy
    a schema:MediaObject, schema:Book, schema:CreativeWork ;
   library:oclcnum "923138142" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/onc> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/2756075967#Topic/surveys_and_questionnaires> ; # Surveys and Questionnaires
   schema:about <http://experiment.worldcat.org/entity/work/data/2756075967#Topic/self_report> ; # Self Report
   schema:about <http://experiment.worldcat.org/entity/work/data/2756075967#Topic/neuralgia_diagnosis> ; # Neuralgia--diagnosis
   schema:about <http://experiment.worldcat.org/entity/work/data/2756075967#Topic/pain_measurement> ; # Pain Measurement
   schema:about <http://experiment.worldcat.org/entity/work/data/2756075967#Topic/mass_screening> ; # Mass Screening
   schema:bookFormat schema:EBook ;
   schema:contributor <http://experiment.worldcat.org/entity/work/data/2756075967#Organization/canadian_agency_for_drugs_and_technologies_in_health> ; # Canadian Agency for Drugs and Technologies in Health.
   schema:contributor <http://experiment.worldcat.org/entity/work/data/2756075967#Organization/canadian_agency_for_drugs_and_technologies_in_health_rapid_response_service> ; # Canadian Agency for Drugs and Technologies in Health. Rapid Response Service,
   schema:datePublished "2015" ;
   schema:description "Compared to nociceptive or inflammatory pain, individuals with neuropathic pain (NP) suffer from more severe disease, greater costs, and relatively reduced health related quality of life. Direct and indirect costs of NP represent a substantial economic burden on the Canadian healthcare system with per patient costs estimated at $2567 ((+/- ) $2711) per three month care period. Neuropathic pain is defined by the International Association for the Study of Pain (IASP) as "pain arising as a direct consequence of a lesion or disease affecting the somatosensory system". The etiology of NP is broad and associated conditions (e.g., cancer, surgery, diabetes, herpes zoster) have been classified into four distinct categories: peripheral nervous system focal and multifocal legions (e.g., post-herpetic neuralgia); peripheral nervous system generalized polyneuropathies (e.g., diabetic neuropathy); central nervous system lesions (e.g., spinal cord injury); and, complex neuropathic disorders including complex regional pain syndrome types I and II. While rates of NP-associated conditions are well documented, rates of NP in the general population are difficult to quantify and under-diagnosed. Studies in the United Kingdom and France that utilized screening tools to identify NP have estimated that 6-8% of patients with chronic pain experience NP in the general population. A single Canadian study that used telephone-based questionnaires for determining NP rates estimated a higher (18%) rate in the general population. Limitations and lack of standardization of diagnostic methods increase the potential for undetected or poorly classified cases. There is no recognized objective gold standard for assessing NP. However, the Special Interest Group on Neuropathic Pain (NeuPSIG) of the IASP has set out a grading system that has been used to guide clinical assessment and diagnosis. This approach involves multiple steps including obtaining a clinical history of pain, assessing the neuroanatomical plausibility of pain, using sensory assessments to confirm nervous system involvement, and running diagnostic tests to confirm nervous system lesions or disease. Other less resource intensive methods of diagnosis have been documented and may be especially useful in primary care. These strategies include, but are not limited to NP screening tools such as: the Douleur Neuropathique 4 (DN4), PainDETECT (PD-Q) the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), and the standardized evaluation of pain (StEP). Screening tools are comprised of an interview component and, in some cases, the addition of a brief bedside clinical assessment. Many of these tools have been translated for application in other languages and populations. Given observed variation in the approach to diagnosis of NP and the significant disease burden, it is of interest to assess the diagnostic accuracy of methods of assessing NP. Improved diagnostic procedures may facilitate improvements in treatment approaches."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/2756075967> ;
   schema:genre "Review"@en ;
   schema:inLanguage "en" ;
   schema:isPartOf <http://worldcat.org/issn/1922-8147> ; # Rapid response report (Canadian Agency for Drugs and Technologies in Health)
   schema:isPartOf <http://experiment.worldcat.org/entity/work/data/2756075967#Series/rapid_response_report_summary_with_critical_appraisal> ; # Rapid response report : summary with critical appraisal
   schema:name "Diagnostic methods for neuropathic pain : a review of diagnostic accuracy"@en ;
   schema:productID "923138142" ;
   schema:url <http://www.ncbi.nlm.nih.gov/books/NBK304863/> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/923138142> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/2756075967#Organization/canadian_agency_for_drugs_and_technologies_in_health> # Canadian Agency for Drugs and Technologies in Health.
    a schema:Organization ;
   schema:name "Canadian Agency for Drugs and Technologies in Health." ;
    .

<http://experiment.worldcat.org/entity/work/data/2756075967#Organization/canadian_agency_for_drugs_and_technologies_in_health_rapid_response_service> # Canadian Agency for Drugs and Technologies in Health. Rapid Response Service,
    a schema:Organization ;
   schema:name "Canadian Agency for Drugs and Technologies in Health. Rapid Response Service," ;
    .

<http://experiment.worldcat.org/entity/work/data/2756075967#Series/rapid_response_report_summary_with_critical_appraisal> # Rapid response report : summary with critical appraisal
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/923138142> ; # Diagnostic methods for neuropathic pain : a review of diagnostic accuracy
   schema:name "Rapid response report : summary with critical appraisal" ;
    .

<http://experiment.worldcat.org/entity/work/data/2756075967#Topic/neuralgia_diagnosis> # Neuralgia--diagnosis
    a schema:Intangible ;
   schema:name "Neuralgia--diagnosis"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2756075967#Topic/surveys_and_questionnaires> # Surveys and Questionnaires
    a schema:Intangible ;
   schema:name "Surveys and Questionnaires"@en ;
    .

<http://worldcat.org/issn/1922-8147> # Rapid response report (Canadian Agency for Drugs and Technologies in Health)
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/923138142> ; # Diagnostic methods for neuropathic pain : a review of diagnostic accuracy
   schema:issn "1922-8147" ;
   schema:name "Rapid response report (Canadian Agency for Drugs and Technologies in Health)" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.